A Clinical Pharmacy Perspective on Drug Utilization and Prescribing Practices in Gastroenterology
The present prospective observational study evaluated the prescription pattern of drugs among patients attending the gastroenterology outpatient department of a tertiary care hospital. A total of 100 prescriptions were assessed over a six-month study period. Patient demographic characteristics, diagnosis, comorbidities, prescribed medicines, number of drugs, duration of therapy, dietary advice, follow-up advice, adverse reactions and lifestyle advice were recorded. Descriptive statistics were used and findings were expressed as frequencies and percentages. Patients aged 46–60 years constituted the largest age group (31%), followed by those above 60 years (28%) and 31–45 years (27%). Females represented 49% and males 51% of the study population. Normal body mass index was recorded in 71% of patients. Gastroesophageal reflux disease was the most frequent listed primary diagnosis (7%). Most patients (58%) received one to two drugs per prescription, while 21% received three to four, 14% received five to six and 7% received more than six drugs. Proton pump inhibitors were the most commonly reported drug category (26%), followed by gastrointestinal prokinetic agents (14%). Therapy continued for more than 30 days in 36% of prescriptions. Comorbidities were absent in 95% of patients. Follow-up was advised in 82%, while adverse reactions were reported in 1% of patients. Dietary advice was not documented in 62% of prescriptions, whereas 26% included a soft diet. The findings demonstrate predominant use of acid-suppressive therapy and variable degrees of polypharmacy, supporting the need for continued prescription review and rational drug-use monitoring in gastroenterology practice.
Authors
- N. Firdous
- M. D. Shahabaz Alam
- S. Babu
- C. Navaneetha
- S. Jyoshna
- M. Ladle
Institutions
- Krishna Institute of Medical Sciences (IN)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-21
- DOI
- https://doi.org/10.5281/zenodo.24414343
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00